10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q /A1

(Mark One)

PQUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  March 31, 2008

oTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from to

Commission file number:0-12968

InMedica Development Corporation

(Exact name of small business issuer as specified in its charter)

UTAH	87-0397815
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

825 North 300 West, Suite N132

Salt Lake City, Utah 84103

(Address of principal executive offices)

(801) 521-9300

(Issuer’s telephone number)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes PNo o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	Accelerated filer
Non-accelerated filer	P Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes oNo P

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:18,629,493 shares of $.001 par value common stock as of May 12, 2008

The Company hereby amends and restates in its entirety, the Consolidated Balance Sheet of the Company filed with Form 10Q for the period ended March 31, 2008 to include comparative data for December 31, 2007, as shown below.

INMEDICA DEVELOPMENT CORPORATION AND SUBSIDIARY

CONSOLIDATED BALANCE SHEET

ASSETS
	As of		As of
	March 31,		December 31,
	2008		2007
	(Unaudited)		(audited)
CURRENT ASSETS:
Cash & cash equivalents	$	11,969	$	2,706
Prepaid expenses and other		200		200
Total current assets		12,169		2,906
EQUIPMENT AND FURNITURE, at cost,
Less accumulated depreciation of
$254,947 and $254,856 respectively		274		365
Total assets	$	12,443	$	3,271

See notes to consolidated financial statements

INMEDICA DEVELOPMENT CORPORATION AND SUBSIDIARY

CONSOLIDATED BALANCE SHEET (Continued)

LIABILITIES AND STOCKHOLDERS' EQUITY
	As of			As of
	March 31,			December 31,
	2008			2007
	(Unaudited)			(audited)
CURRENT LIABILITIES:
Related party consulting fees payable	$	84,000		$	78,000
Accounts payable		21,232			5,503
Accrued payroll		12,000			-
Accrued interest		20,362			16,495
Related party royalty payable		83,333			73,333
Preferred stock dividend payable		51,069			49,177
Current portion of long term debt		140,000			60,617
Total current liabilities		411,996			283,125
LONG TERM LIABILITIES
Long term convertible promissory note		85,033			140,000
TOTAL LIABILITIES		497,029			423,125
MINORITY INTEREST		(217,169	)		(191,668	)
STOCKHOLDERS' EQUITY:
Preferred stock, 10,000,000 shares authorized;
Series A preferred stock, cumulative and
convertible, $4.50 par value,
1,000,000 shares designated,
21,016 shares issued and outstanding		94,573			94,573
Common stock, $.001 par value;
40,000,000 shares authorized,
18,629,493 issued and outstanding		18,629			18,629
Additional paid-in capital		8,426,839			8,426,839
Accumulated deficit		(8,807,458	)		(8,768,227	)
Total stockholders equity		(267,417	)		(228,186	)
Total liabilities and stockholders' equity	$	12,443		$	3,271

See notes to consolidated financial statements

Item 6.                    Exhibits:

(31.1)                      Sarbanes-Oxley Section 302 Certification – Ralph Henson

(31.2)                      Sarbanes- Oxley Section 302 Certification- Richard Bruggeman

(32.1)                      Sarbanes-Oxley Section 906 Certification

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized.

INMEDICA DEVELOPMENT CORPORATION

/s/ Ralph Henson

By  Ralph Henson, President

/s/ Richard Bruggeman

By  Richard Bruggeman, Treasurer

Date:   September  26 , 2008

EXHIBIT INDEX - INMEDICA DEVELOPMENT CORPORATION

FORM 10Q /A1 – MARCH 31, 2008

EXHIBIT NUMBER DESCRIPTION

(31.1)                       Sarbanes-Oxley Section 302 Certification – Ralph Henson

(31.2)                       Sarbanes- Oxley Section 302 Certification- Richard Bruggeman

(32.1)                       Sarbanes-Oxley Section 906 Certification

EX-31.1

 

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Ralph Henson, certify that:

1. I have reviewed this quarterly report on Form 10-Q /A1 of InMedica Development Corporation.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report.

4. The small business issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the small business issuer and have:

a)  Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d   Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over the financial reporting; and

5. The small business issuer’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.

Date:   September 22 , 2008

/s/ Ralph Henson

Ralph Henson,

President

EX-31.2

Exhibit 31.2

CERTIFICATE PURSUANT TO SECTION 302

OF THE SABANES-OXLEY ACT OF 2002

I, Richard Bruggeman, certify that:

1. I have reviewed this quarterly report on Form 10-Q /A1 of InMedica Development Corporation.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report.

4. The small business issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the small business issuer and have:

a)    Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over the financial reporting; and

5. The small business issuer’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.

Date:   September 26 , 2008

/s/ Richard Bruggeman

Richard Bruggeman,

Chief Financial Officer

EX-32

Exhibit 32.1 CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies in his capacity as an officer of InMedica Development Corporation (the Company) that the Quarterly Report of the Company on Form 10Q /A1 for the quarter ended March 31, 2008 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition of the Company at the end of such periods and the results of operations of the Company for such periods.

/s/ Ralph Henson

Ralph Henson,

Chief Executive Officer

September 22, 2008

/s/ Richard Bruggeman

Richard Bruggeman,

Chief Financial Officer

September 26, 2008